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In one of the preceding papers of this series (1) it was shown that 
formolization  of  tissue  suspensions  containing  the  active  virus  of 
equine encephalomyelitis inactivates the virus.  This is reflected by 
the complete loss of infectivity of even large amounts of material after 
inoculation by various routes in  guinea pigs and mice  (1,  2).  Yet 
formolized vaccines induce in these animals a high grade of resistance, 
as  evidenced by development of immunity to  as much as  1,000  to 
10,000 M.I~.D. of virus given intracerebrally.  The protection afforded 
compares favorably, within certain limits, with that evoked by un- 
treated  active  virus--indeed  with  the  same  suspensions  of  active 
virus employed in the preparation of formolized vaccines.  In another 
article (3)  reference was made to the fact that the antigenic complex 
existing in active as well as in inactive virus produces practically the 
same  amount  of  humoral  antiviral  bodies.  The  formolization  of 
tissue suspensions of equine encephalomyelitis virus can therefore be 
regarded as a means of inactivating the virus and at the same time of 
preserving the antigenicity of the suspension. 
In this communication a study is presented on the effects of immune 
serum on the antigenic capacity of active and of formolized virus. 
Methods and Materials 
The methods and materials as employed in  these experiments, including  the 
Eastern strain of equine encephalomyelitis virus, have already been described in 
the preceding paper (3).  Since guinea pig hyperimmune serum was found to be 
more potent than ordinary immune serum, the former (Tables I  and II, Paper 
III (3)) was used.  This serum, under optimal conditions of time and temperature 
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(2} hours at 37°C.), neutralized 1,000 to 10,000 M°L.D. of virus, as manifested by 
the results of the mouse intracerebral test (3). 
The mode of procedure in an experiment  was as follows: 1 cc. of hyperimmune 
serum was injected into subcutaneous tissue of the abdomen of guinea pigs and 1 
hour later, 1 cc. of active or formolized  virus was inoculated under the skin of the 
opposite side.  The animals received two  such courses of treatment at 7 days' 
interval and were tested for induced immunity by intracerebral inoculation  t of 
>  1,000 <  10,000 ~.L.D. of virus given 16 days after the last immunizing  dose. 
It will be observed from the protocols to be presented that the amount of serum 
alone, as given, did not suffice  to confer passive immunity. 
Immune Serum Followed by Active  Virus 
In a  preliminary experiment, one series of guinea pigs was given 
active  virus  alone  and  another  undiluted immune  serum  followed 
within an hour by the same virus.  The outcome yielded results which 
prompted us to conduct another experiment with different dilutions of 
immune serum and with both active and inactive virus. 
The  results  of  the  preliminary test  are  summarized in  Table  I. 
When active virus alone was used, of guinea pigs receiving two injec- 
tions of 3  ×  105 or more mouse infective units of virus (m.i.u.) (1, 4), 
seven of seventeen succumbed to virus infection during the period of 
immunization, the incidence of death being proportional to the amount 
of  virus  introduced.  Of  the  survivors,  however,  all  proved  to  be 
resistant to an intracerebral test of  > 1,000 < 10,000 ~.L.D. of virus. 
On the other hand, those given 3  ×  104 or less m.i.u, of virus survived 
the treatment but only one of eight was found immune to the test for 
induced  resistance.  The  findings are  in  agreement with  our  prior 
observations (1, 4). 
When undiluted hyperimmune serum was injected in advance of the 
virus,  all  guinea pigs  survived the  two  courses  of inoculation, but 
none of them proved to  be  resistant to  the described intracerebral 
test.  Iq  other words,  in  each instance  and with concentrations of 
virus ranging from 3  ×  10  s to  3  ×  10s  m.i.u., the relatively small 
amount of immune serum prevented the antigenic action of the sus- 
pensions of active virus. 
This blocking effect of undiluted immune serum on the antigenic 
stimulus of active virus might be considered merely as the result of 
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preventive action of the serum on multiplication of the virus after its 
introduction in the body, thus producing less antigenic substance and 
in turn no resistance on the part of the host.  That this is not the 
mode of action can be deduced from the next series of experiments. 
These  were  planned  to  determine  the  results  yielded  by  smaller 
TABLE  I 
Guinea Pigs Receiving Hyperimmune Guinea Pig Serum and Active Virus or Active 
Virus Alone 
Quantity. of undiluted 
serum in each dose 
1  CC. 
None 
1 CC. 
None 
1 cc. 
None 
1 CC. 
None 
1 CC. 
None 
1 CC. 
None 
1 cc. 
M.i.u. of virus in 
each dose 
3  X  lO  s 
3 X  10  7 
3  X  10  6 
3X  10  6 
3X10  ~ 
3X10  s 
Jl~  lC 
None 
Animals showing 
fever of 104°F. 
or above 
3/4 
4/4 
2/4 
2/4 
o/4 
3/4 
2/4 
1/5 
1/4 
1/4 
1/4 
0/4 
0/4 
Animals surviving 
virus infection 
during immuniza- 
tion period 
4/4 
1/4 
4/4 
3/4 
4/4 
2/4 
4/4 
4/5 
4/4 
4/4 
4/4 
4/4 
4/4 
Immunity test 
Survivors of an 
intracerebral test of 
>  1,000  < 10,000 
~.L.V. given 16 
days later 
0/4 
1/1 
0/4 
3/3 
0/4 
2/2 
0/4 
4/4 
"  0/4 
1/4 
0/4 
O/4 
O/4 
Animals were given two courses of serum and virus or virus alone at 7 days' 
interval  In instances in which serum was used, it was followed an hour later 
by a  subcutaneous injection of active  virus on  the opposite side.  Weight of 
animals  ffi  275 to 325 gin.  Denominator represents the number of animals in 
each test. 
amounts of serum and to disclose any blocking effect of both diluted 
and  undiluted  immune  serum  exerted against  virus  inactivated  by 
formalin.  For in the latter material no active virus could be demon- 
strated  (1)--hence no probability of its  multiplication in rico--and 
still a  sufficient amount of antigenic substance was present to induce 
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Immune Serum Followed by Active and Inactive Virus 
In  the  following  experiment  devised  to  reveal  any  comparable 
preventive effect in vivo of immune serum on the  antigenic capacity 
of  active  and  of inactive  virus,  the  antigens  employed  consisted  of 
two materials.  The first was active virus as was present in the brain 
of mice that succumbed to experimental encephalomyelitis.  This was 
employed in doses of 3  X  107 m.i.u.,  a  potent immunizing quantity, 
and  in  doses  of  3  X  10  * m.i.u.,  the  minimal  quantity  required  to 
immunize  guinea  pigs  against  an  intracerebral  test  of  1,000  ~r.L.D. 
of  virus.  The  second  consisted  of  formolized  vaccine.  The  last 
preparation which was shown to be free of demonstrable active virus 
(1)  was made from the same virus tissue suspension employed in the 
first  material  just  mentioned,  and  hence  contained  3  X  10 z m.i.u. 
before  formolization.  The  data  of  this  experiment  are  shown  in 
Table II and are summarized as follows: 
Untreated, Active Virus (3 X  107 M.i.u.) as Antigen.--With a dose of 3  X  107 
m.i.u, of virus given 1 hour after the same undiluted serum as was described  in 
Table I, all animals survived the courses of treatment but none became immune. 
With  1:4  dilution  of  serum,  again  all  animals survived;  they  were,  however, 
proved to be resistant to a later intracerebral test.  Finally, with 1:8 or higher 
dilutions of serum, ten of thirty-one animals succumbed to virus infection during 
the period of immunization, and all survivors withstood the intracerebral test of 
> 1,000  < 10,000 ~.L.D. given 20 days after the last immunizing dose. 
Untreated, Active Virus  in Minimal Immunizing  Quantity (3  ×  105 M.i.u.) 
as Antigen.--When 3  ×  l0  s m.i.u, of virus was used, preceded by an injection of 
either undiluted or 1:4 dilution of immune serum, all animals so inoculated lived 
through the treatment but only one of eight was found to withstand the intra- 
cerebral test for induced immunity.  With  1:8 and 1:16 dilutions of serum, all 
animals survived the subcutaneous injections; three of eight failed, however, to 
resist the immunity test.  With 1:32 or higher dilutions of serum, four of twenty- 
four guinea pigs died of virus infection during the courses  of injections but all 
survivors except one were successfully  immunized to the test dose. 
Virus Inactivated by Formalin.--Of  eight guinea pigs that received formolized 
vaccine preceded by the administration of either undiluted  or  1:4 dilutions of 
serum, none succumbed during the period of this treatment and none was found 
immune to the later intracerebral test.  With  1:8 and 1:16 dilutions of serum, 
all animals withstood the injections and only three of eight the test for immunity. 
The twenty-four guinea pigs given 1:32 or higher dilutions of serum survived the 
inoculations,  and  all but  two,  the later intracerebral test of  >1,000  <10,000 
M.L.D.  of virus. TABLE  II 
Vaccination  of Guinea  Pigs with Hyperimmune Guinea  Pig Serum and  Active  or 
Fornwlized Virus 
Dilution of serum 
Undiluted 
1:4 
1:8 
1:16 
1:32 
1:64 
1:128 
1:256 
1:512 
1:1,024 
M.i.u. of virus in each dose 
Active  virus 
3  X  10  7 
3XlO s 
3  X  10  7 
3XlO ~ 
3  X  107 
3XlO ~ 
3  X  l0  T 
3X105 
3  X  107 
3XlO ~ 
3  X  10  7 
3X10  6 
3  X  107 
3XlO ~ 
3  X  10  7 
3XlO 6 
3  X  10  7 
3XlO  5 
3 X  107 
3XlO 5 
Formolizcd vaccine 
3  X  107 
3  X  107 
3  X  107 
n 
3  X  10  7 
3  X  107 
3  X 107 
3  X  107 
3  X  107 
3 ×  107 
3  ×  107 
Animals Su~vivlng 
virus infection 
during immunlza- 
t.ion period 
4/4 
2/3* 
4/4 
L~ 
2/4 
3/4 
4/4 
3//4 
gC 
4/4 
1/4 
4/4 
3/4 
4/4 
2/4 
3/4 
4/4 
3/4 
4/4 
Immunity test 
Animals surviving 
an intracerebral 
test of >1,000 
< I0,000 K.L.D. 
given 20 days later 
0/4 
~c 
4/4 
1/4 
0/4 
2/2 
2//4 
4/4 
3/4 
1/4 
2/2 
2/3 
3/4 
3/3 
4/4 
1/1 
4/4 
3/4 
3/3 
4/4 
cg 
2/2 
3/3 
4/4 
~g 
3/3 
4/4 
Animals received two courses of serum and virus at  7 days' interval.  Serum 
injection followed an hour later by an injection of either active or formolized virus 
on the opposite side.  Weight of animals  =  275 to 325 gm. 
* One  of  the  animals  in  this group  died of an intercurrent,  streptococcal  in- 
fection. 
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From these experiments it is evident that hyperimmune serum in 
sufficient quantity injected shortly before the antigen can prevent or 
block the immunizing action not only of untreated active virus but 
also of formolized inactive virus.  Indeed, the preventive action of 
1 cc. of serum is effectively exerted against about 30 million (Table II) 
to 300 million (Table I) infective units of virus; less serum is needed, 
however, to block the antigenic capacity of the smaller amount of 
active  agent  (300,000  infective units)  than of the larger.  At  this 
point attention is directed to the fact that with the same serum dilu- 
tions, similar results were obtained with formolized vaccine to those 
with 3 X  105 m.i.u, of active virus--the minimal effective immunizing 
dose (Table II). 
Relation  to  Immunization  with Serum-Virus  Combinations.--These 
experiments, taken together with others carried out by Howitt  (5), 
whose results have been confirmed by our own observations, also have 
a bearing on the immunization  of guinea pigs by means of combinations 
of immune serum and active virus.  It should be stressed that both 
materials  should be  introduced into  the  animal in  certain  definite 
proportions if the desired immunity without death from virus infection 
during the period of immunization is to be attained.  Thus with the 
particular hyperimmune serum studied (Table II)  and with 3 ×  107 
m.i.u, of virus, the optimal conditions for inducing immunity were 
achieved by employing 1:4 dilution of serum; with 3  ×  106 m.i.u., 
1:16  to  1:64  dilutions.  Furthermore, the proper  dilution of  each 
individual immune serum sample should be determined by test with 
each individual quantity of active virus employed. 
Equine encephalomyelitis virus differs in this respect from certain 
other virus agents, such as yellow fever, in which "when the optimal 
amount of immune serum has been ascertained, a wide range of virus 
concentration can be used with success"  (6)  for immunization.  It 
is clear, nevertheless, that formolized vaccines containing inactivated 
equine encephalomyelitis virus could replace injections of combined 
serum and virus for the immunization of guinea pigs with elimination 
of the necessary, laborious, serum titrations. 
It has been assumed that generally antiserum in neutralized and 
overneutralized suspensions of virus employed for artificial immuniza- 
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inhibiting the multiplication of virus and thus the production of more 
antigen in the body.  The results of the foregoing experiments show 
that in so far as the encephalomyelitis virus is concerned, the serum 
blocks the development of immunity in  the instance in  which sus- 
pensions  containing  inactivated,  nonmultiplying  virus  are  used  as 
immunizing preparations. 
SU~rMARY A~D DISCUSSION 
A  study was undertaken on the effect in vivo, in the guinea pig, of 
equine encephalomyelitis virus antiserum upon the antigenic response 
to active, as compared with that to formolized, inactive virus.  It was 
found that when animals were given subcutaneously a proper amount 
of hyperimmune serum 1 hour before inoculation, in the subcutis, of 
either active or of inactive virus, no immunity was induced against an 
intracerebral test of more than  1,000  and less than  10,000  M.LD. of 
virus.  This preventive power of the serum was lost by its dilution, 
the loss being proportional to the dilution, and, on the other hand, 
more serum was needed to obtain the blocking effect as the quantity 
of  virus  was  increased.  When  an  insufficient  amount  of  serum 
was introduced into  the animals along with the same quantities of 
active virus or formolized vaccine, a certain number of those receiving 
the untreated virus succumbed to virus infection in the course of the 
inoculations, but the survivors were rendered resistant to the intra- 
cerebral test; all the guinea pigs treated with higher dilutions of serum 
and with formolized material were brought safely to an immune state. 
The point to  be stressed then is that antigenic stimuli present in 
untreated active virus and in formolized virus tissue suspensions in 
which no active virus is demonstrable by drastic tests (1)  and which 
are wholly noninfective in animals (1), are completely inhibited from 
acting by the use of proper amounts of immune serum. 
The  mechanism  underlying  this  preventive  power  of  adequate 
amounts of serum may be explained on the basis of facts deduced in 
preceding papers of this series (1, 3) and in the present article.  We 
have shown that 3  ×  107 m.i.u, of active virus contains a  sufficient 
amount of antigen to induce immunity without the necessity of its 
multiplication in the animal body.  This has been fully established by 
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virus formolized to a degree in which no active virus could be revealed 
(1).  The assumption that the blocking effect of serum in the quantity 
employed prevents multiplication of the virus which is reflected in the 
production of inadequate amounts of antigen, is therefore untenable, 
since this effect was obtained when a sufficient amount of antigen was 
present in "living" as well as in "killed" virus.  On the other hand, 
with insufficient amounts of immune serum (to  be noted in higher 
dilutions shown in Table II), only the active virus could multiply-- 
the formolized vaccine was not affected in respect to its antigenicity by 
these quantities of serum--and so produce more antigenic substance. 
This substance, in turn, brought about greater resistance in the host. 
The precise action of proper amounts of serum in preventing de- 
velopment of  immunity by  both  active  and  inactive  virus  is  not 
definitely known.  However, two hypotheses are offered for consid- 
eration: the first implies that the action of the serum is direct, that is, 
by  entering  into  combination with  the  antigens  to  bar  antigenic 
capacity; the second ascribes to the serum an indirect action, on the 
cells of the body, in such a way as to make them unable to react to 
the antigenic stimuli present in the inoculated materials. 
The identity of these antigenic stimuli in virus suspensions con- 
taining the active, infective agent or this agent inactivated by formalin 
is  at  the  present time undetermined.  If  virus were  obtainable  in 
pure state, free from extraneous material, the answer to this question 
might be readily given, but it is quite a  different matter when the 
substance called virus is a  mixture of the infective agent, of inflam- 
matory tissue products, of tissue, etc.  We have, however, shown that 
induced immunity is not due to the presence of "living" virus, but 
whether the antigenic action originates from "killed" virus or from 
another  constituent of  the  suspension is  not  clear.  On  the  other 
hand, Sabin (7) suggests the possibility that the virus may not be the 
direct antigenic stimulus but that some substance on which it acts 
and which becomes liberated from infected cells may be the factor 
responsible.  While this subject awaits  the results of further study, 
we believe that formalin inactivates the infective agent in virus sus- 
pensions and preserves the antigenic component therein, whatever its 
nature may be. 
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capacity by proper amounts of immune serum might apply to  such 
materials which by their very nature do not multiply in the body of the 
host,  e.g.,  toxin and antitoxin.  Theobald Smith  (8)  and later  Park 
(9)  demonstrated  that  in  mixtures  of  diphtheria  toxin-antitoxin, 
when smaller  amounts of immune serum  (antitoxin)  are  used,  the 
toxicity of the mixture is retained and immunity results; if the serum 
is increased, toxicity is reduced and immunity occurs irregularly, and 
if more serum is added,  no toxicity nor immunity results.  This is 
supported by the experiments of Hartley  (10) on washed precipitates 
from  underneutralized,  neutral,  and  overneutralized  mixtures  of 
antitoxin  and  toxin:  those  derived  from  underneutralized  material 
are toxic and powerfully antigenic; those from neutralized, atoxic and 
of good antigenic action, and from overneutralized, atoxic and of low 
antigenicity.  Hartley states, moreover, that the precipitate reactions 
of toxicity and antigenicity bear a  close relationship to the nature of 
the mixture from which they are produced. 
There is, therefore, a  connection between the preventive reactions 
of the serum on the two forms of virus and of antitoxin on toxin in 
respect  to  toxicity  and  antigenicity.  Furthermore,  the  toxin  is 
rendered atoxic with retention of immunizing capacity by formalin: 
the  production  of  toxoid  or  anatoxin  (Glenny  and  Hopkins  (11), 
Ramon  (12))--again  a  condition  related  to  the  effects  following 
formolization of the virus.  It has, however, been stated that "in an 
immunizing mixture prepared with modified [formolized, but partially 
detoxified]  toxin  the  antitoxin  present  does  not within  wide limits 
affect the antigenic power"  (Glenny, Hopkins, and  Pope  (13)).  It 
is not known whether a preliminary injection of antitoxic serum could 
have prevented the antigenic power of fully detoxified toxin, that is, 
after  the passive immunity induced by the serum disappears.  If a 
preventive action of antitoxic serum could be shown under these cir- 
cumstances,  a  remarkable  correlation  of  the  reactions  of  proper 
amounts of  antitoxin  to  toxoid  and  of proper  amounts of  immune 
serum on the virus would be evident. 
Finally, the inhibition of antigenic power of both active and inactive 
virus by immune serum has been demonstrated to apply to the virus 
of equine encephalomyelitis in guinea pigs and no generalizations of 
the application of the phenomenon to other viruses are intended. 232  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  IV 
CONCLUSION 
In active equine encephalomyelitis virus and in the virus inactivated 
by formalin, there is a sufficient amount of antigen, without necessity 
of multiplication in  the body,  to  produce immunity in  guinea pigs 
against  >1,000  <10,000  intracerebral  lethal  doses  of  virus.  The 
antigenic capacity of both materials can be blocked to the same extent 
by  the  action  of  an  appropriate  amount  of  hyperimmune serum. 
The bearing of these findings on the mechanism of immunity induced 
by virus inactivated by formalin is discussed. 
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